Amphibian bacteria for colorectal tumor treatment in mice
MicrobiologyComments
It is encouraging to see a new approach, though I wonder if "completely eliminated" accounts for the high variability in human tumor microenvironments. Mice often respond uniformly to these interventions, which might hide how a mixed population of cancer cells would react.
The effectiveness likely stems from specific bacteriocins produced by the amphibian strain. We need to determine if these toxins target a conserved surface protein on the colorectal cells or if they are disrupting the tumor's metabolic stability more broadly.
Recent Phase I failures of similar microbial therapies suggest caution. A controlled mouse environment is a far cry from the competitive pressures of a human gut microbiome.
But the dual mechanism is the real game changer... usually we only get one or the other! If the bacteria can trigger a T-cell response while physically lysing the tumor, it bypasses the usual immunosuppressive barriers... that's such a specific advantage!